OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,644,061 | +9.4% | 214,094 | -20.0% | 0.00% | 0.0% |
| Q2 2023 | $2,416,040 | +925585.8% | 267,557 | +255.7% | 0.00% | – |
| Q1 2023 | $261 | -85.5% | 75,224 | -89.8% | 0.00% | -100.0% |
| Q4 2022 | $1,803 | -99.9% | 735,953 | +8.5% | 0.00% | 0.0% |
| Q3 2022 | $1,873,000 | -28.5% | 678,598 | +5.5% | 0.00% | -50.0% |
| Q2 2022 | $2,618,000 | +619.2% | 643,344 | +653.2% | 0.00% | – |
| Q1 2022 | $364,000 | -84.3% | 85,417 | -65.6% | 0.00% | -100.0% |
| Q4 2021 | $2,324,000 | +742.0% | 248,328 | +2383.3% | 0.00% | – |
| Q3 2021 | $276,000 | -69.1% | 10,000 | -46.1% | 0.00% | -100.0% |
| Q4 2020 | $892,000 | – | 18,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |